Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Tam FWK"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-14 z 14
    Tytuł:
    Primary IgA nephropathy: current challenges and future prospects
    Autorzy:
    Penfold RS
    Prendecki M
    McAdoo S
    Tam FWK
    Pokaż więcej
    Temat:
    IgA nephropathy
    glomerulonephritis
    immunosuppression
    chronic kidney disease
    Diseases of the genitourinary system. Urology
    RC870-923
    Źródło:
    International Journal of Nephrology and Renovascular Disease, Vol Volume 11, Pp 137-148 (2018)
    Opis pliku:
    electronic resource
    Relacje:
    https://www.dovepress.com/primary-iga-nephropathy-current-challenges-and-future-prospects-peer-reviewed-article-IJNRD; https://doaj.org/toc/1178-7058
    Dostęp URL:
    https://doaj.org/article/6184ec9ecd4c47b0874525654565fcf6  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Association and progression of multi-morbidity with Chronic Kidney Disease stage 3a secondary to Type 2 Diabetes Mellitus, grouped by albuminuria status in the multi-ethnic population of Northwest London: A real-world study.
    Autorzy:
    Dattani R; Imperial College London, London, United Kingdom.
    Ul-Haq Z; Imperial College Health Partners, London, United Kingdom.
    Shah M; Imperial College Health Partners, London, United Kingdom.
    Goldet G; Imperial College Healthcare NHS Trust, London, United Kingdom.
    Darzi LA; Imperial College London, London, United Kingdom.
    Ashrafian H; Imperial College London, London, United Kingdom.
    Kamalati T; Imperial College Health Partners, London, United Kingdom.
    Frankel AH; Imperial College Healthcare NHS Trust, London, United Kingdom.
    Tam FWK; Imperial College London, London, United Kingdom.; Imperial College Healthcare NHS Trust, London, United Kingdom.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2023 Aug 25; Vol. 18 (8), pp. e0289838. Date of Electronic Publication: 2023 Aug 25 (Print Publication: 2023).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Diabetes Mellitus, Type 2*/complications
    Diabetes Mellitus, Type 2*/epidemiology
    Renal Insufficiency, Chronic*/complications
    Renal Insufficiency, Chronic*/epidemiology
    Hypertension*
    Heart Failure*
    Humans ; Multimorbidity ; Albuminuria/complications ; London ; Morbidity ; Aldosterone ; Mineralocorticoid Receptor Antagonists
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Impact of kidney size on the outcome of diabetic patients receiving hemodialysis.
    Autorzy:
    Wang M; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Linkou, and Chang Gung University, Taoyuan, Taiwan.
    Hsu HC; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Linkou, and Chang Gung University, Taoyuan, Taiwan.
    Yu MC; Division of Pediatric Nephrology, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, and Chang Gung University, Taoyuan, Taiwan.
    Wang IK; Department of Nephrology, China Medical University Hospital, Taichung, and China Medical University, Taichung, Taiwan.
    Huang CC; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Linkou, and Chang Gung University, Taoyuan, Taiwan.
    Chan MJ; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Linkou, and Chang Gung University, Taoyuan, Taiwan.
    Weng CH; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Linkou, and Chang Gung University, Taoyuan, Taiwan.
    Huang WH; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Linkou, and Chang Gung University, Taoyuan, Taiwan.
    Hsu CW; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Linkou, and Chang Gung University, Taoyuan, Taiwan.
    Huang LM; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Linkou, and Chang Gung University, Taoyuan, Taiwan.
    Tam FWK; Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom.
    Yen TH; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Linkou, and Chang Gung University, Taoyuan, Taiwan.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2022 Mar 31; Vol. 17 (3), pp. e0266231. Date of Electronic Publication: 2022 Mar 31 (Print Publication: 2022).
    Typ publikacji:
    Journal Article; Observational Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Diabetes Mellitus*/etiology
    Kidney Failure, Chronic*
    Humans ; Kidney ; Longitudinal Studies ; Renal Dialysis/adverse effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization.
    Autorzy:
    Tempest-Roe S; Department of Immunology & Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK. .
    Prendecki M; Department of Immunology & Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK.
    McAdoo SP; Department of Immunology & Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
    Clarke C; Department of Immunology & Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK.
    Tanna A; Imperial College Healthcare NHS Trust, London, UK.
    Turner-Stokes T; Department of Immunology & Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK.
    Masuda ES; Rigel Pharmaceuticals Incorporated, South San Francisco, CA, USA.
    Willicombe M; Department of Immunology & Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
    Cook HT; Department of Immunology & Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
    Roufosse C; Department of Immunology & Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
    Taube D; Department of Immunology & Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
    Pusey CD; Department of Immunology & Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
    Tam FWK; Department of Immunology & Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2022 Feb 28; Vol. 12 (1), pp. 3330. Date of Electronic Publication: 2022 Feb 28.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Kidney Transplantation*/adverse effects
    Animals ; Antibodies ; Graft Rejection ; Humans ; Oxazines/pharmacology ; Oxazines/therapeutic use ; Pyridines/pharmacology ; Pyridines/therapeutic use ; Rats ; Rats, Inbred F344 ; Syk Kinase ; Tissue Donors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Masked crystalline light chain tubulopathy and podocytopathy with focal segmental glomerulosclerosis: a rare MGRS-associated renal lesion.
    Autorzy:
    Kousios A; West London Renal and Transplant Centre, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College, London, UK.
    Mcadoo S; West London Renal and Transplant Centre, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College, London, UK.
    Blakey S; West London Renal and Transplant Centre, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College, London, UK.
    Moran L; Department of Cellular Pathology, North West London Pathology, Imperial College Healthcare NHS Trust, London, UK.
    Atta M; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London and Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
    Tam FWK; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College, London, UK.
    Cook HT; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College, London, UK.; Department of Cellular Pathology, North West London Pathology, Imperial College Healthcare NHS Trust, London, UK.
    Chaidos A; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London and Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
    Roufosse C; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College, London, UK.; Department of Cellular Pathology, North West London Pathology, Imperial College Healthcare NHS Trust, London, UK.
    Pokaż więcej
    Źródło:
    Histopathology [Histopathology] 2021 Aug; Vol. 79 (2), pp. 265-268. Date of Electronic Publication: 2021 May 17.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Glomerulosclerosis, Focal Segmental*/diagnosis
    Glomerulosclerosis, Focal Segmental*/pathology
    Paraproteinemias*/diagnosis
    Paraproteinemias*/pathology
    Humans ; Kidney/pathology ; Middle Aged ; Podocytes/pathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Impact of kidney size on mortality in diabetic patients receiving peritoneal dialysis.
    Autorzy:
    Chen CH; Department of Orthopedic Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan.
    Chen CY; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Chang Gung University, 199 Tung Hwa North Road, Linkou, Taoyuan, Taipei, 105, Taiwan.
    Yu MC; Division of Pediatric Nephrology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University, Linkou, Taoyuan, Taiwan.
    Fu JF; Department of Medical Research, Chang Gung Memorial Hospital, Linkou, and Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
    Hou YC; Division of Nephrology, Department of Internal Medicine, Cardinal Tien Hospital, School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan.
    Wang IK; Department of Nephrology, China Medical University Hospital, China Medical University, Taichung, Taiwan.
    Chih YH; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Chang Gung University, 199 Tung Hwa North Road, Linkou, Taoyuan, Taipei, 105, Taiwan.
    Weng CH; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Chang Gung University, 199 Tung Hwa North Road, Linkou, Taoyuan, Taipei, 105, Taiwan.
    Huang WH; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Chang Gung University, 199 Tung Hwa North Road, Linkou, Taoyuan, Taipei, 105, Taiwan.
    Hsu CW; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Chang Gung University, 199 Tung Hwa North Road, Linkou, Taoyuan, Taipei, 105, Taiwan.
    Tam FWK; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.
    Yen TH; Department of Nephrology, Clinical Poison Center, Kidney Research Center, Center for Tissue Engineering, Chang Gung Memorial Hospital, Chang Gung University, 199 Tung Hwa North Road, Linkou, Taoyuan, Taipei, 105, Taiwan. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2021 Apr 15; Vol. 11 (1), pp. 8203. Date of Electronic Publication: 2021 Apr 15.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Peritoneal Dialysis*/statistics & numerical data
    Diabetic Nephropathies/*mortality
    Kidney/*pathology
    Kidney Failure, Chronic/*mortality
    Aged ; Aged, 80 and over ; Diabetic Nephropathies/pathology ; Diabetic Nephropathies/therapy ; Female ; Humans ; Kidney Failure, Chronic/pathology ; Kidney Failure, Chronic/therapy ; Longitudinal Studies ; Male ; Middle Aged ; Organ Size ; Survival Analysis ; Taiwan/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Modification of an aggressive model of Alport Syndrome reveals early differences in disease pathogenesis due to genetic background.
    Autorzy:
    Falcone S; Mammalian Genetics Unit, Medical Research Council, Harwell science and innovation campus, Oxford, OX11 0RD, UK.
    Wisby L; Mammalian Genetics Unit, Medical Research Council, Harwell science and innovation campus, Oxford, OX11 0RD, UK.
    Nicol T; Mammalian Genetics Unit, Medical Research Council, Harwell science and innovation campus, Oxford, OX11 0RD, UK.
    Blease A; Mammalian Genetics Unit, Medical Research Council, Harwell science and innovation campus, Oxford, OX11 0RD, UK.
    Starbuck B; Mammalian Genetics Unit, Medical Research Council, Harwell science and innovation campus, Oxford, OX11 0RD, UK.
    Parker A; Mammalian Genetics Unit, Medical Research Council, Harwell science and innovation campus, Oxford, OX11 0RD, UK.
    Sanderson J; Mammalian Genetics Unit, Medical Research Council, Harwell science and innovation campus, Oxford, OX11 0RD, UK.
    Brown SDM; Mammalian Genetics Unit, Medical Research Council, Harwell science and innovation campus, Oxford, OX11 0RD, UK.
    Scudamore CL; Mary Lyon Centre, Medical Research Council, Harwell science and innovation campus, Oxford, OX11 0RD, UK.
    Pusey CD; Renal and Vascular Inflammation Section, Department of Medicine, Imperial College, London, W12 0N, UK.
    Tam FWK; Renal and Vascular Inflammation Section, Department of Medicine, Imperial College, London, W12 0N, UK.
    Potter PK; Renal and Vascular Inflammation Section, Department of Medicine, Imperial College, London, W12 0N, UK. .; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, OX3 0BP, UK. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2019 Dec 31; Vol. 9 (1), pp. 20398. Date of Electronic Publication: 2019 Dec 31.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Genetic Background*
    Mutation*
    Collagen Type IV/*genetics
    Nephritis, Hereditary/*genetics
    Animals ; Disease Models, Animal ; Disease Progression ; Genetic Predisposition to Disease ; Kidney/metabolism ; Mice ; Mice, Inbred C3H ; Mice, Inbred C57BL ; Nephritis, Hereditary/metabolism ; Podocytes/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    P2X7 Receptor Stimulation Is Not Required for Oxalate Crystal-Induced Kidney Injury.
    Autorzy:
    Luz HL; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Centre of inflammatory disease, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK.
    Reichel M; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
    Unwin RJ; Centre for Nephrology, Royal Free Hospital, University College London, London, UK.
    Mutig K; Department of Vegetative Anatomy, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Pharmacology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
    Najenson AC; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.
    Tonner LM; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
    Eckardt KU; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.
    Tam FWK; Centre of inflammatory disease, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK.
    Knauf F; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany. .; Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2019 Dec 27; Vol. 9 (1), pp. 20086. Date of Electronic Publication: 2019 Dec 27.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Kidney Calculi/*chemically induced
    Oxalates/*toxicity
    Purinergic Agonists/*pharmacology
    Receptors, Purinergic P2X7/*drug effects
    Adenosine Triphosphate/metabolism ; Animals ; Caspase 1/genetics ; Humans ; Interleukin-1beta/metabolism ; Mice ; Mice, Inbred C57BL ; Receptors, Purinergic P2X7/genetics ; Uric Acid/toxicity
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy.
    Autorzy:
    Nguyen C; Department of Biomedicine, University of Basel, Basel, Switzerland.
    König K; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
    Tam FWK; Renal and Transplant Centre, Renal and Vascular Inflammation Section, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK.
    Hopfer H; Institute for Pathology, University Hospital Basel, Basel, Switzerland.
    Molyneux K; Department of Infection, Immunity & Inflammation, University of Leicester, Leicester, UK.
    Binet FI; Clinic for Nephrology and Transplantation Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.
    Kim MJ; Department of Biomedicine, University of Basel, Basel, Switzerland.; Clinic for Nephrology and Transplantation Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.
    Pokaż więcej
    Źródło:
    Clinical kidney journal [Clin Kidney J] 2018 Aug 03; Vol. 12 (2), pp. 232-238. Date of Electronic Publication: 2018 Aug 03 (Print Publication: 2019).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    P2X 7 receptor antagonism ameliorates renal dysfunction in a rat model of sepsis.
    Autorzy:
    Arulkumaran N; Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.; Division of Medicine, Department of Nephrology, University College London, London, United Kingdom.; Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
    Sixma ML; Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.
    Pollen S; Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.
    Ceravola E; Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.
    Jentho E; Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.
    Prendecki M; Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
    Bass PS; Division of Medicine, Department of Nephrology, University College London, London, United Kingdom.; Department of cellular pathology, Royal Free hospital, London, United Kingdom.
    Tam FWK; Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
    Unwin RJ; Division of Medicine, Department of Nephrology, University College London, London, United Kingdom.
    Singer M; Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.
    Pokaż więcej
    Źródło:
    Physiological reports [Physiol Rep] 2018 Mar; Vol. 6 (5).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Acute Kidney Injury/*drug therapy
    Anti-Inflammatory Agents/*therapeutic use
    Peritonitis/*drug therapy
    Purinergic P2X Receptor Antagonists/*therapeutic use
    Pyridines/*therapeutic use
    Shock, Septic/*drug therapy
    Tetrazoles/*therapeutic use
    Acute Kidney Injury/etiology ; Animals ; Cells, Cultured ; Creatinine/blood ; Interleukin-1beta/blood ; Male ; Peritonitis/complications ; Rats ; Rats, Wistar ; Shock, Septic/etiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-14 z 14

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies